Marshall D. Brown

发表

Identification of Prognostic Biomarkers in the Urinary Peptidome of the Small Renal Mass.

G. Yousef, E. Diamandis, A. Finelli, 2019, The American journal of pathology.

Assessing the Clinical Impact of Risk Prediction Models With Decision Curves: Guidance for Correct Interpretation and Appropriate Use.

Kathleen F. Kerr, Kathleen F Kerr, Holly Janes, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Evaluating the impact of policies recommending PrEP to subpopulations of men and transgender women who have sex with men based on demographic and behavioral risk factors

D. Glidden, S. Buchbinder, K. Mayer, 2019, PloS one.

Reply to A.J. Vickers et al.

K. Kerr, H. Janes, Marshall D. Brown, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Adjusting for covariates in evaluating markers for selecting treatment, with application to guiding chemotherapy for treating estrogen-receptor-positive, node-positive breast cancer.

W. Barlow, Dave P. Miller, H. Janes, 2017, Contemporary clinical trials.

Prognostic Urinary miRNAs for the Assessment of Small Renal Masses.

G. Yousef, E. Diamandis, A. Finelli, 2019, Clinical biochemistry.

Neuronal pentraxin receptor-1 is a new cerebrospinal fluid biomarker of Alzheimer’s disease progression

M. Tsolaki, E. Diamandis, Ioulietta Lazarou, 2018, F1000Research.

Statistical Methods for Evaluating and Comparing Biomarkers for Patient Treatment Selection

M. Pepe, H. Janes, Ying Huang, 2013 .

An Approach to Evaluating and Comparing Biomarkers for Patient Treatment Selection

Holly Janes, Margaret S Pepe, Ying Huang, 2014, The international journal of biostatistics.

17-Gene Genomic Prostate Score Test Results in the Canary Prostate Active Surveillance Study (PASS) Cohort.

J. Brooks, P. Nelson, J. McKenney, 2020, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Evaluating the Four Kallikrein Panel of the 4Kscore for Prediction of High-grade Prostate Cancer in Men in the Canary Prostate Active Surveillance Study.

M. Cooperberg, P. Carroll, J. Brooks, 2017, European urology.

Serum complexed and free prostate specific antigen levels are lower in female elite athletes in comparison to control women

E. Diamandis, Yingye Zheng, E. Glezer, 2017, F1000Research.

E. Diamandis, V. Magdolen, E. Martínez-Morillo, 2018, Journal of proteomics.

Evaluating incremental values from new predictors with net reclassification improvement in survival analysis

Yingye Zheng, Tianxi Cai, Layla Parast, 2013, Lifetime data analysis.

Performance of PCA3 and TMPRSS2:ERG urinary biomarkers in prediction of biopsy outcome in the Canary Prostate Active Surveillance Study (PASS)

M. Cooperberg, P. Carroll, J. Brooks, 2018, Prostate Cancer and Prostatic Diseases.

Serum complexed and free prostate-specific antigen (PSA) for the diagnosis of the polycystic ovarian syndrome (PCOS)

E. Diamandis, Yingye Zheng, R. Azziz, 2017, Clinical chemistry and laboratory medicine.

Designing a study to evaluate the benefit of a biomarker for selecting patient treatment

Holly Janes, Margaret S Pepe, M. Pepe, 2015, Statistics in medicine.

Searching for prognostic biomarkers for small renal masses in the urinary proteome

G. Yousef, E. Diamandis, A. Finelli, 2020, International journal of cancer.

Assessing the Clinical Impact of Risk Models for Opting Out of Treatment

K. Kerr, H. Janes, Marshall D. Brown, 2019, Medical decision making : an international journal of the Society for Medical Decision Making.

Evaluating incremental values from new predictors with net reclassification improvement in survival analysis

T. Cai, Layla Parast, Yingye Zheng, 2013, Lifetime data analysis.

Validation of a Novel Biomarker Panel for the Detection of Ovarian Cancer

R. Bast, E. Diamandis, Yingye Zheng, 2016, Cancer Epidemiology, Biomarkers & Prevention.

Performance of PCA3 and TMPRSS2:ERG urinary biomarkers in prediction of biopsy outcome in the Canary Prostate Active Surveillance Study (PASS)

M. Cooperberg, P. Carroll, J. Brooks, 2018, Prostate Cancer and Prostatic Diseases.

Liquid biopsy of cerebrospinal fluid identifies neuronal pentraxin receptor (NPTXR) as a biomarker of progression of Alzheimer’s disease

M. Tsolaki, E. Diamandis, I. Prassas, 2019, Clinical chemistry and laboratory medicine.

IMPROVING EFFICIENCY IN BIOMARKER INCREMENTAL VALUE EVALUATION UNDER TWO-PHASE DESIGNS.

Tianxi Cai, Yingye Zheng, Marshall Brown, 2017, The annals of applied statistics.

Dynamic prediction of risk of liver‐related outcomes in chronic hepatitis C using routinely collected data

A. Lok, Yingye Zheng, M. Konerman, 2016, Journal of viral hepatitis.

Evaluating the Four Kallikrein Panel of the 4Kscore for Prediction of High-grade Prostate Cancer in Men in the Canary Prostate Active Surveillance Study.

M. Cooperberg, P. Carroll, J. Brooks, 2017, European urology.

Validation of a Novel Biomarker Panel for the Detection of Ovarian Cancer

R. Bast, E. Diamandis, Yingye Zheng, 2016, Cancer Epidemiology, Biomarkers & Prevention.